SecBot SecBot
SC 13G ·Filed Oct 8, 2026

EYE

National Vision Holdings, Inc.
NEUTRAL
Impact 3/10
Horizonweeks Processed19d 6h ago SEC0000354204-26-001057
Passive investor 5%+ stake
Actionable Insight • Neutral

Monitor for any future amendments that show a material increase or decrease in Dimensional's position, which could signal a shift in conviction. No immediate catalyst from this routine passive disclosure.

DirectionNeutral
Confidencehigh
Horizonweeks
Latest settled — T+5d
EYE ▲ +5.50% at T+5d
NEUTRAL call +5.50% · α vs SPY +5.77% · entry $16.74 → $17.66
Next anchor: T+20d in 8d
Latest observation: T+11 +14.62% FF3 residual α
Entry = T+0 close
Oct 8, 2026
via day close
T+1d
-0.36%
call -0.36% · α -0.96%
$16.68
settled 19d ago
T+5d
+5.50%
call +5.50% · α +5.77%
$17.66
settled 13d ago
T+20d
Pending
in 8d
T+60d
Pending
in 2mo

Price Chart

Loading chart...

Executive Summary

Dimensional Fund Advisors LP disclosed a 5.1% passive stake in National Vision Holdings, Inc. via a new Schedule 13G filing, reporting beneficial ownership of 4,060,926 common shares as of September 30, 2026. This is a routine passive investment disclosure by a large quantitative asset manager, indicating no intent to influence management.

Key Financial Metrics

Stake
5.1%
Investor
Dimensional Fund Advisors LP

Key Facts

  • Dimensional Fund Advisors LP filed a new Schedule 13G disclosing a 5.1% passive stake in National Vision Holdings, Inc.
  • The stake comprises 4,060,926 shares of common stock as of September 30, 2026.
  • Dimensional is a registered investment adviser and holds the shares on behalf of various funds; it disclaims beneficial ownership.
  • The filing certifies the shares were acquired in the ordinary course of business and not to influence control.
  • This is a new filing (not an amendment) for Dimensional; prior passive stakes in EYE were held by Wellington Management and FMR/Fidelity.

Financial Impact

Passive 5.1% stake; no direct financial impact from the filing itself.

Risk Factors

  • No material risks identified from this passive stake filing.

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G Filing (Primary)0000354204-26-001057
Document: 0000354204-26-001057-index.html0000354204-26-001057
Document: 0000354204-26-001057.txt0000354204-26-001057
4 reports for EYE
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for EYE — sortable, filterable
TypeNow
Oct 8, 2026
19d ago
SC 13G
NEUTRAL ★ 3/10
$16.74awaiting T+60—$17.80 (+6.33%)
Sep 2, 2026
8w ago
Court Ruling
NEUTRAL ★ 1/10
$16.87awaiting T+60—$17.80 (+5.51%)
Jun 16, 2026
19w ago
Institutional Cluster
BULLISH ★ 6/10
$17.57 $17.13▼ −2.50%▼ −3.50%$17.80 (+1.31%)
Jun 9, 2026
20w ago
Insider Buy
NEUTRAL ★ 3/10
$17.58 $16.87▼ −4.04%▼ −10.62%$17.80 (+1.25%)
Showing 4 of 4

US Market Status

Market Closed — Opens Thu (12h 52m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 8, 2026